- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Honeywell completes acquisition of research chemicals business from Sigma-Aldrich
5 February 2016 • Author: Honeywell
Honeywell (NYSE: HON) today announced that it has completed the acquisition of the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich, broadening Honeywell’s offerings for high-purity solutions for drug discovery, medical diagnostic testing and other laboratory applications.
The acquisition includes the Fluka-branded solvents and inorganic chemistry portfolio worldwide and the Sigma-Aldrich-branded solvents and inorganic chemistry portfolio in the European Economic Area (EEA). Those offerings are now part of Honeywell’s broader portfolio of offerings for research chemicals, which already includes the Riedel-de Haën® and Burdick & Jackson® brands.
“The combined Honeywell business will be able to serve a broader range of customers and applications with global brands recognized for world-class quality and lot-to-lot consistency – essential for a range of applications including drug synthesis, food, environmental, chemical and forensic testing,” said Qamar Bhatia, president of Honeywell’s Specialty Products business. “To make the transition process as seamless as possible, customers will still order products directly through Sigma-Aldrich and receive the same level of dedicated customer, technical and logistical support as they always have.”
The Honeywell portfolio now includes six product lines:
- Fluka® chemicals and reagents used for biochemical research and other chemical and pharmaceutical applications
- Hydranal® Karl Fischer titration reagents used by laboratories to measure moisture content in liquids and solids
- Chromasolv® high-purity solvents for chromatography, a technique used to separate and analyze complex mixtures
- Riedel-de Haën® high-quality research chemicals used in pharmaceutical production and bioscience
- Burdick & Jackson® high-purity solvents, reagents and chromatography products for laboratories and pharmaceutical production
- Sigma-Aldrich® solvents and inorganics sold into the European Economic Area
The acquired business employs approximately 200 people, primarily in Seelze, with sales and marketing personnel throughout Europe. Honeywell’s Seelze plant, which manufactures Riedel-de Haën-branded products, currently makes the majority of the products in the acquired business.
The acquired business will be integrated into Honeywell’s Fine Chemicals business and will continue to be led by the core leadership team of the acquired company. With two production sites, Seelze and Muskegon, Mich., in the U.S., the combined business unit will be able to develop and manufacture high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications.
With the addition of titration products, high-purity solvents and reagents, and specialty inorganic chemicals, Honeywell builds on an already strong portfolio of Burdick & Jackson and Riedel-de Haën products. Honeywell’s Fine Chemicals business has supplied high-quality research chemicals and specialty organic and inorganic compounds to the chemical and pharmaceutical industries for more than 100 years. Its products are sold under the Burdick & Jackson and Riedel-de Haën brands, and are used in a variety of laboratory, consumer and industrial applications including drug discovery, toothpaste, water purification, fortified foodstuffs, polymer synthesis, and metal surface treatment and finishing.
Honeywell Fine Chemicals is a part of the Honeywell Performance Materials and Technologies business group.
Honeywell Performance Materials and Technologies (PMT) is a global leader in developing advanced materials, process technologies and automation solutions. PMT’s Advanced Materials businesses manufacture a wide variety of high-performance products, including environmentally friendlier refrigerants and materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips and pharmaceutical packaging. Process technologies developed by PMT’s UOP business form the foundation for most of the world’s refiners, efficiently producing gasoline, diesel, jet fuel, petrochemicals and renewable fuels. PMT’s Process Solutions business is a pioneer in automation control, instrumentation and services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals and mining industries.
Honeywell is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes, and industry; turbochargers; and performance materials. For more news and information on Honeywell, please visit www.honeywellnow.com.
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics